UAB 1360: Immune Modulation by Addition of Oral Lenalidomide to Intravesical BCG (Bacille Calmette-Guerrin) for Therapy of Non-Muscle-Invasive Transitional Cell Bladder Cancer

Grant

Date/time Interval

  • February 14, 2014 - February 13, 2019

    • Awarded By

    Total Award Amount

  • 19519.00

    • Direct Costs

  • 15491.00

    • Sponsor Award Id

    • Contributor

  • Mollie Deshazo M.D.   Investigator  
  • Sunil Sudarshan M.D.   Investigator